Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring
-
Published:2020-09-07
Issue:1
Volume:11
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Sun NaORCID, Lee Yi-TeORCID, Zhang Ryan Y.ORCID, Kao Rueihung, Teng Pai-Chi, Yang YingyingORCID, Yang PengORCID, Wang Jasmine J., Smalley MatthewORCID, Chen Pin-JungORCID, Kim MinhyungORCID, Chou Shih-Jie, Bao Lirong, Wang JingORCID, Zhang XinyueORCID, Qi DongpingORCID, Palomique Juvelyn, Nissen Nicolas, Han Steven-Huy B., Sadeghi Saeed, Finn Richard S., Saab Sammy, Busuttil Ronald W., Markovic Daniela, Elashoff David, Yu Hsiao-huaORCID, Li HuiyingORCID, Heaney Anthony P., Posadas Edwin, You SungyongORCID, Yang Ju DongORCID, Pei RenjunORCID, Agopian Vatche G.ORCID, Tseng Hsian-RongORCID, Zhu YazhenORCID
Abstract
AbstractWe report a covalent chemistry-based hepatocellular carcinoma (HCC)-specific extracellular vesicle (EV) purification system for early detection of HCC by performing digital scoring on the purified EVs. Earlier detection of HCC creates more opportunities for curative therapeutic interventions. EVs are present in circulation at relatively early stages of disease, providing potential opportunities for HCC early detection. We develop an HCC EV purification system (i.e., EV Click Chips) by synergistically integrating covalent chemistry-mediated EV capture/release, multimarker antibody cocktails, nanostructured substrates, and microfluidic chaotic mixers. We then explore the translational potential of EV Click Chips using 158 plasma samples of HCC patients and control cohorts. The purified HCC EVs are subjected to reverse-transcription droplet digital PCR for quantification of 10 HCC-specific mRNA markers and computation of digital scoring. The HCC EV-derived molecular signatures exhibit great potential for noninvasive early detection of HCC from at-risk cirrhotic patients with an area under receiver operator characteristic curve of 0.93 (95% CI, 0.86 to 1.00; sensitivity = 94.4%, specificity = 88.5%).
Funder
U.S. Department of Health & Human Services | National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference62 articles.
1. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A. & Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018). 2. Tsuchiya, N., Sawada, Y., Endo, I., Saito, K., Uemura, Y. & Nakatsura, T. Biomarkers for the early diagnosis of hepatocellular carcinoma. World J. Gastroenterol. 21, 10573–10583 (2015). 3. Marrero, J. A. et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68, 723–750 (2018). 4. Forner, A. & Bruix, J. Biomarkers for early diagnosis of hepatocellular carcinoma. Lancet Oncol. 13, 750–751 (2012). 5. Heitzer, E., Haque, I. S., Roberts, C. E. S. & Speicher, M. R. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat. Rev. Genet. 20, 71–88 (2019).
Cited by
157 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|